Investor Relations
Jul 16, 2018
OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada MORE >>
Jun 11, 2018
OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity MORE >>
May 18, 2018
OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test MORE >>
May 08, 2018
OPKO Health Reports First Quarter 2018 Financial Results MORE >>

Code of Business Conduct and Ethics

Code of Business Conduct and Ethics Introduction

The Board has adopted a Code of Business Conduct and Ethics that applies to all of our directors, officers (including our Chief Executive Officer, our Chief Financial Officer, and our principal accounting officer), and employees.

Notice of Amendment:
On June 14, 2012, the Company's Board of Directors amended its Code of Business Conduct and Ethics to, among other things, further define various transactions which would constitute a conflict of interest, include provisions prohibiting usurpation of corporate opportunities, impose requirements of fair dealing and confidentiality, and clarify various reporting procedures and obligations for responding to government investigations and media or public inquiries.

Click here for OPKO's Code of Business Conduct and Ethics